Cocrystal Pharma and Bristol-Myers Squibb are competing for investment as healthcare companies.
1 report, 1 independent
Updated Sep 27
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Cocrystal Pharma and Bristol-Myers Squibb are competing for investment as healthcare companies.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Cocrystal Pharma
company in Bothell, United States
Nothing else this week.
-
Bristol-Myers Squibb
American pharmaceutical company
Related events
- AstraZeneca sought a mega-merger with a US rival, adding a specific development to the ongoing talks with Bristol-Myers Squibb.
- Bristol-Myers Squibb and AbbVie secured regulatory approval for a therapy in the US.
- AbbVie, Johnson & Johnson, Bristol-Myers Squibb, and Amgen are innovating targeted, cost-effective therapies for psoriatic arthritis.
- Biopharma leaders from major companies gathered in Copenhagen to discuss commercial strategies and AI utilization.